Literature DB >> 23054532

Synthesis of 2-arylamino substituted 5,6-dihydropyrido[2,3-d]pyrimidine-7(8H)-ones from arylguanidines.

Iñaki Galve1, Raimon Puig de la Bellacasa, David Sánchez-García, Xavier Batllori, Jordi Teixidó, José I Borrell.   

Abstract

A practical protocol was developed for the synthesis of 2-arylamino substituted 4-amino-5,6-dihydropyrido[2,3-d]pyrimidin-7(8H)-ones from α,β-unsaturated esters, malononitrile, and an aryl substituted guanidine via the corresponding 3-aryl-3,4,5,6- tetrahydropyrido[2,3-d]pyrimidin-7(8H)-ones. Such compounds are formed upon treatment of 2-methoxy-6-oxo-1,4,5,6-tetrahydropyridine-3-carbonitriles with an aryl substituted guanidine in 1,4-dioxane and are converted to the desired 4-aminopyridopyrimidines with NaOMe/MeOH through a Dimroth rearrangement. The overall yields of this three-step protocol are, generally speaking, higher than the multicomponent reaction, previously developed by our group, between an α,β-unsaturated ester, malononitrile, and an aryl substituted guanidine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054532     DOI: 10.1007/s11030-012-9398-6

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  13 in total

1.  A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants.

Authors:  David R Huron; Mercedes E Gorre; Alan J Kraker; Charles L Sawyers; Neal Rosen; Mark M Moasser
Journal:  Clin Cancer Res       Date:  2003-04       Impact factor: 12.531

2.  PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia.

Authors:  Nicholas C Wolff; Darren R Veach; William P Tong; William G Bornmann; Bayard Clarkson; Robert L Ilaria
Journal:  Blood       Date:  2005-01-18       Impact factor: 22.113

3.  Synthesis and biological activity of 7-oxo substituted analogues of 5-deaza-5,6,7,8-tetrahydrofolic acid (5-DATHF) and 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF).

Authors:  J I Borrell; J Teixidó; J L Matallana; B Martínez-Teipel; C Colominas; M Costa; M Balcells; E Schuler; M J Castillo
Journal:  J Med Chem       Date:  2001-07-05       Impact factor: 7.446

4.  Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors.

Authors:  J M Hamby; C J Connolly; M C Schroeder; R T Winters; H D Showalter; R L Panek; T C Major; B Olsewski; M J Ryan; T Dahring; G H Lu; J Keiser; A Amar; C Shen; A J Kraker; V Slintak; J M Nelson; D W Fry; L Bradford; H Hallak; A M Doherty
Journal:  J Med Chem       Date:  1997-07-18       Impact factor: 7.446

5.  2-Methoxy-6-oxo-1,4,5,6-tetrahydropyridine-3-carbonitriles: versatile starting materials for the synthesis of libraries with diverse heterocyclic scaffolds.

Authors:  Blanca Martínez-Teipel; Jordi Teixidó; Rosalia Pascual; Marta Mora; Josep Pujolà; Ted Fujimoto; José I Borrell; Enrique L Michelotti
Journal:  J Comb Chem       Date:  2005 May-Jun

6.  The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells.

Authors:  J F Dorsey; R Jove; A J Kraker; J Wu
Journal:  Cancer Res       Date:  2000-06-15       Impact factor: 12.701

7.  An unusual Michael addition of 3,3-dimethoxypropanenitrile to 2-aryl acrylates: a convenient route to 4-unsubstituted 5,6-dihydropyrido[2,3-d]pyrimidines.

Authors:  Xavier Berzosa; Xavier Bellatriu; Jordi Teixidó; José I Borrell
Journal:  J Org Chem       Date:  2010-01-15       Impact factor: 4.354

8.  A one-pot microwave-assisted synthesis of pyrido[2,3-d]pyrimidines.

Authors:  Núria Mont; Jordi Teixidó; C Oliver Kappe; José I Borrell
Journal:  Mol Divers       Date:  2003       Impact factor: 2.943

9.  Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.

Authors:  David Wisniewski; Caryl L Lambek; Chongyuan Liu; Annabel Strife; Darren R Veach; Bhushan Nagar; Matthew A Young; Thomas Schindler; William G Bornmann; Joseph R Bertino; John Kuriyan; Bayard Clarkson
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

10.  Novel heterocycle-substituted pyrimidines as inhibitors of NF-kappaB transcription regulation related to TNF-alpha cytokine release.

Authors:  Hyung-Ho Ha; Jee Seon Kim; B Moon Kim
Journal:  Bioorg Med Chem Lett       Date:  2007-11-22       Impact factor: 2.823

View more
  2 in total

1.  The Dimroth Rearrangement in the Synthesis of Condensed Pyrimidines - Structural Analogs of Antiviral Compounds.

Authors:  Vakhid А Mamedov; Nataliya А Zhukova; Milyausha S Kadyrova
Journal:  Chem Heterocycl Compd (N Y)       Date:  2021-05-15       Impact factor: 1.277

Review 2.  Pyrido[2,3-d]pyrimidin-7(8H)-ones: Synthesis and Biomedical Applications.

Authors:  Guillem Jubete; Raimon Puig de la Bellacasa; Roger Estrada-Tejedor; Jordi Teixidó; José I Borrell
Journal:  Molecules       Date:  2019-11-16       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.